KBC Group
LEGN icon

KBC Group’s Legend Biotech LEGN Stock Holding History

KBC Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Sell
7,612
-11,902
-61% -$227K ﹤0.01% 1131
2025
Q4 		$424K Hold
19,514
– – ﹤0.01% 739
2025
Q3 		$636K Buy
19,514
+2,431
+14% +$89.8K ﹤0.01% 693
2025
Q2 		$606K Sell
17,083
-9,965
-37% -$323K ﹤0.01% 690
2025
Q1 		$918K Buy
27,048
+13,904
+106% +$499K ﹤0.01% 674
2024
Q4 		$428K Hold
13,144
– – ﹤0.01% 840
2024
Q3 		$641K Hold
13,144
– – ﹤0.01% 703
2024
Q2 		$582K Hold
13,144
– – ﹤0.01% 708
2024
Q1 		$737K Sell
13,144
-2,787
-17% -$168K ﹤0.01% 697
2023
Q4 		$959K Buy
15,931
+522
+3% +$33.1K ﹤0.01% 695
2023
Q3 		$1.03M Sell
15,409
-942
-6% -$65.4K ﹤0.01% 677
2023
Q2 		$1.13M Sell
16,351
-1,000
-6% -$65.3K ﹤0.01% 684
2023
Q1 		$837K Sell
17,351
-1,200
-6% -$58.7K ﹤0.01% 732
2022
Q4 		$926K Sell
18,551
-2,108
-10% -$102K ﹤0.01% 698
2022
Q3 		$843K Sell
20,659
-1,309
-6% -$61.4K ﹤0.01% 691
2022
Q2 		$1.21M Sell
21,968
-10,897
-33% -$460K 0.01% 635
2022
Q1 		$1.19M Buy
32,865
+7,035
+27% +$278K ﹤0.01% 673
2021
Q4 		$1.2M Buy
25,830
+5,702
+28% +$289K ﹤0.01% 692
2021
Q3 		$1.02M Sell
20,128
-34,380
-63% -$1.43M ﹤0.01% 757
2021
Q2 		$2.24M Hold
54,508
– – ﹤0.01% 755
2021
Q1 		$1.58M Buy
54,508
+10,770
+25% +$294K ﹤0.01% 789
2020
Q4 		$6.77M Sell
43,738
-90,594
-67% -$2.61M ﹤0.01% 821
2020
Q3 		$4.15M Buy
+134,332
New +$4.52M 0.01% 583

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

KBC Group's LEGN Position: Q1 2026 in Review

KBC Group reduced its Legend Biotech (LEGN) stake by 61% in Q1 2026, selling an estimated $227K and leaving 7,612 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

KBC Group first reported a position in LEGN in Q3 2020 and has held it in 23 quarters since. The position peaked at $6.77M in Q4 2020. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • KBC Group held 7,612 shares of Legend Biotech worth $138K as of Q1 2026.
  • KBC Group sold 11,902 Legend Biotech shares in Q1 2026, an estimated $227K.
  • Legend Biotech made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1131 holding.
  • KBC Group first reported a position in Legend Biotech in Q3 2020 and has held it in 23 quarters since.
  • KBC Group's Legend Biotech position peaked at $6.77M in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.